Terms: = Sarcomas AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
126 results:
1. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
[TBL] [Abstract] [Full Text] [Related]
2. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.
Takeda T; Tsubaki M; Genno S; Tomita K; Nishida S
Exp Cell Res; 2024 Mar; 436(2):113978. PubMed ID: 38382805
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of anlotinib-induced autophagy attenuates invasion and migration by regulating epithelial-mesenchymal transition and cytoskeletal rearrangement through ATG5 in human osteosarcoma cells.
Zheng B; Sun X; Zhang L; Qu G; Ren C; Yan P; Zhou C; Yue B
Braz J Med Biol Res; 2024; 57():e13152. PubMed ID: 38381883
[TBL] [Abstract] [Full Text] [Related]
4. Arctigenin Suppresses the Proliferation and Metastasis, and Induces Apoptosis and Cycle Arrest of Osteosarcoma Cells by inhibiting HMOX1 Expression.
Xu G; He Z; Liu Y
Anticancer Agents Med Chem; 2023; 23(20):2209-2216. PubMed ID: 37711016
[TBL] [Abstract] [Full Text] [Related]
5. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and emt signalling pathways.
Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
[TBL] [Abstract] [Full Text] [Related]
6. Solasonine Inhibits Cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma.
Wang B; Zhou Y; Zhang P; Li J; Lu X
Am J Chin Med; 2023; 51(5):1293-1308. PubMed ID: 37367817
[TBL] [Abstract] [Full Text] [Related]
7. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
[TBL] [Abstract] [Full Text] [Related]
8. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract] [Full Text] [Related]
9. Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line.
Hodge MA; Miller T; Weinman MA; Wustefeld-Janssens B; Bracha S; Davis BW
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980828
[TBL] [Abstract] [Full Text] [Related]
10. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.
Yang M; Zhang H; Gao S; Huang W
J Orthop Surg Res; 2023 Feb; 18(1):145. PubMed ID: 36849972
[TBL] [Abstract] [Full Text] [Related]
11. Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1.
Li J; Zhang Y; Sun F; Zhang G; Pan XA; Zhou Q
Orthop Surg; 2023 Apr; 15(4):1060-1071. PubMed ID: 36782343
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway.
Sun MX; An HY; Sun YB; Sun YB; Bai B
J Orthop Surg Res; 2022 Dec; 17(1):557. PubMed ID: 36544170
[TBL] [Abstract] [Full Text] [Related]
13. TYMSOS-miR-101-3p-NETO2 axis promotes osteosarcoma progression.
Zhang Z; Wang J; Zhang X; Ran B; Wen J; Zhang H
Mol Cell Probes; 2023 Feb; 67():101887. PubMed ID: 36509232
[TBL] [Abstract] [Full Text] [Related]
14. A Feedback Loop of LINC00665 and the Wnt Signaling Pathway Expedites Osteosarcoma Cell Proliferation, Invasion, and Epithelial-Mesenchymal Transition.
Bai J; Zhang X; Jiang F; Shan H; Gao X; Bo L; Zhang Y
Orthop Surg; 2023 Jan; 15(1):286-300. PubMed ID: 36387061
[TBL] [Abstract] [Full Text] [Related]
15. The mechanism of VCP-mediated metastasis of osteosarcoma based on cell autophagy and the emt pathway.
Li AA; Zhang Y; Li F; Zhou Y; Liu ZL; Long XH
Clin Transl Oncol; 2023 Mar; 25(3):653-661. PubMed ID: 36284060
[TBL] [Abstract] [Full Text] [Related]
16. Pseudoangiosarcomatous squamous cell carcinoma: a rare subtype of squamous cell carcinoma that needs to be differentiated from angiosarcoma and has a poor prognosis.
Zhan Y; Wan H; Wu L; Ge X; Xie X; Wu L; Cai Y
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):62-66. PubMed ID: 36227677
[TBL] [Abstract] [Full Text] [Related]
17. Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.
Ho GY; Kyran EL; Bedo J; Wakefield MJ; Ennis DP; Mirza HB; Vandenberg CJ; Lieschke E; Farrell A; Hadla A; Lim R; Dall G; Vince JE; Chua NK; Kondrashova O; Upstill-Goddard R; Bailey UM; Dowson S; Roxburgh P; Glasspool RM; Bryson G; Biankin AV; ; Cooke SL; Ratnayake G; McNally O; Traficante N; ; DeFazio A; Weroha SJ; Bowtell DD; McNeish IA; Papenfuss AT; Scott CL; Barker HE
Cancer Res; 2022 Dec; 82(23):4457-4473. PubMed ID: 36206301
[TBL] [Abstract] [Full Text] [Related]
18. Curculigoside Represses the Proliferation and Metastasis of Osteosarcoma via the JAK/STAT and NF-κB Signaling Pathways.
Guo H; Zheng L; Guo Y; Han L; Yu J; Lai F
Biol Pharm Bull; 2022; 45(10):1466-1475. PubMed ID: 36184504
[TBL] [Abstract] [Full Text] [Related]
19. Hydroxygenkwanin suppresses proliferation, invasion and migration of osteosarcoma cells via the miR‑320a/SOX9 axis.
Dong X; Wang Y; Zhuang H; An G
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929504
[TBL] [Abstract] [Full Text] [Related]
20. Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features.
Miao L; Ma ST; Jiang X; Zhang HH; Wang YM; Li M
BMC Med Imaging; 2022 Jul; 22(1):131. PubMed ID: 35883116
[TBL] [Abstract] [Full Text] [Related]
[Next]
